BSETrident Texofab LtdMediumNeutral
Announced Wed, 4 Jun · 18:46 IST

Conversion of 4,81,907 warrants into 4,81,907 equity shares of face value of Rs. 10/- each

Warrants ConvertedQip At PremiumFund Raising View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Trident Texofab's board approved conversion of 4,81,907 warrants into equity shares of Rs. 10 face value at an issue price of Rs. 70 per share (including Rs. 60 premium). The company received Rs. 2.53 crore as the balance 75% payment from 6 non-promoter allottees. After this conversion, the company's paid-up capital increased to Rs. 14.99 crore, comprising 1,49,95,764 equity shares. About 9,11,479 warrants remain pending for conversion within the 18-month window from the original December 2024 allotment.

Likely market impact

This is a dilution event for existing shareholders as new shares are being issued, but the company is also receiving fresh capital (Rs. 2.53 crore) from warrant holders exercising their conversion rights. The stock may see minor pressure due to increased share count, though the issuance was already pre-announced in December 2024.